COGNIZANT TECHNOLOGY SOLUTIONS CORP annual report, FY2023

Cognizant Technology Solutions Corporation — FY2023 Form 10-K

Reporting period: Fiscal year ended December 31, 2023; filed February 14, 2024. This is an annual filing, and the supplied filing text does not provide a clear standalone fourth-quarter income statement or cash-flow summary.

Business context

Cognizant provides consulting, technology, digital, application, infrastructure, security and business-process services. It reports four segments: Financial Services (FS), Health Sciences (HS), Products and Resources (P&R), and Communications, Media and Technology (CMT). Approximately 347,700 employees were employed at year-end, down from 355,300 in 2022.

Financial performance and liquidity

MetricFY2023FY2022
Revenue$19.353 billion$19.428 billion
Operating income / margin$2.689 billion / 13.9%$2.968 billion / 15.3%
Adjusted operating income / margin$2.918 billion / 15.1%$2.968 billion / 15.3%
Net income$2.126 billion$2.290 billion
Diluted EPS$4.21$4.41
Adjusted diluted EPS$4.55$4.40
Cash from operations$2.330 billion$2.568 billion
Free cash flow$2.013 billion$2.236 billion

Adjusted results and free cash flow are non-GAAP measures. FY2023 included $229 million of NextGen restructuring charges; adjusted measures exclude those charges. The effective income tax rate was 24.0%, versus 24.2% in 2022.

  • Segment revenue: FS $5.809 billion (down 4.3%); HS $5.674 billion (up 0.8%); P&R $4.628 billion (up 1.4%); CMT $3.242 billion (up 2.6%).
  • Balance sheet and liquidity: Cash and cash equivalents were $2.621 billion and short-term investments $14 million. Total debt was approximately $639 million, including $33 million current and $606 million long-term. The $1.85 billion revolving facility had no balance outstanding; approximately $2.0 billion of credit capacity was available.
  • Capital returns: FY2023 dividends were $1.16 per share. The company repurchased approximately $1.064 billion of shares during the year; $1.777 billion remained authorized under its repurchase program at year-end.

Material changes versus FY2022

  • Revenue declined $75 million, or 0.4% (0.3% in constant currency). Management cited reduced discretionary client spending, especially in North America, and weakness in banking. Acquisitions contributed 110 basis points to revenue growth.
  • GAAP operating margin fell 140 basis points to 13.9%; adjusted operating margin fell 20 basis points to 15.1%. Higher compensation costs, including two merit cycles, weighed on margins; NextGen savings, rupee depreciation and improved profitability on a large Health Sciences contract partly offset the pressure.
  • Net income fell 7.2% and diluted EPS fell 4.5%. Adjusted diluted EPS increased 3.4%.
  • Operating cash flow declined $238 million, primarily due to higher income-tax payments. The company reported approximately $300 million of tax payments related to capitalization of research and experimental expenditures for the 2022 tax year, as well as approximately $230 million of estimated 2023 tax payments.
  • Voluntary Tech Services attrition declined to 13.8% from 25.6% in 2022.

Outlook, risks and unusual items

  • The NextGen program is expected to conclude by the end of 2024. Total costs are estimated at approximately $300 million, including $229 million incurred in 2023 and approximately $70 million expected in 2024. The program aims to simplify operations and generate savings for investment; actual costs, timing and benefits may differ.
  • Management expects continued client focus on digital transformation and plans significant investment in AI capabilities. It cautions that AI and automation could also replace some existing services, reduce demand or pressure pricing. The filing text does not provide a clear quantified FY2024 revenue or earnings guidance figure.
  • Key operating risks include macroeconomic uncertainty and discretionary-spending reductions, client contract terminations, competition, talent costs and retention, foreign exchange, cybersecurity and privacy, and evolving AI and regulatory requirements.
  • India tax dispute: Indian authorities assert an additional tax liability of 33 billion rupees (about $397 million) related to a 2016 subsidiary share repurchase. Cognizant disputes the claim and recorded no reserve. In January 2024, it deposited 30 billion rupees (about $355 million) to proceed with its appeal; this amount was represented by time deposits under lien. A separate 2013 transaction remains in litigation, with no specific tax demand reported.
  • Other contingencies: A trade-secret and contract case against Syntel was remanded for further damages proceedings after the Second Circuit affirmed liability but vacated a $570 million damages award component. Cognizant will not recognize a gain until realizable. The company also reports a $117 million accrual for India defined-contribution obligations, whose ultimate amount remains uncertain.
  • Management reported no cybersecurity threats in 2023 that materially affected, or were reasonably likely to materially affect, the company. It disclosed a significant 2020 ransomware incident that caused disruption and unauthorized access to certain data.
  • In January 2024, Cognizant acquired Thirdera for a preliminary purchase price of $430 million. A quarterly dividend of $0.30 per share was approved in February 2024.

Important facts for investors to verify

  • Whether discretionary client spending recovers, particularly in FS and North America, and whether recent large deals ramp as expected.
  • Whether NextGen delivers expected savings and completes within the estimated cost and timing.
  • The outcomes and cash implications of the Indian tax dispute, Syntel damages proceedings and India employee-benefit obligation.
  • Whether cash generation remains sufficient to fund acquisitions, dividends and buybacks while meeting tax, lease and debt obligations.
  • How AI investment affects new bookings, service demand, pricing and margins, and whether management provides quantified forward guidance.